WILLIAMS AND JENSEN, PLLC for NOVARTIS INC
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Tax application of ACA section 9008 to orphan drugs; H.R. 2029, Division Q.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER W HATCHER | — |
| CHERYL LYNN JAEGER | — |
| GEORGE OLSEN | — |
Medicare/Medicaid MMM
Medicare prescription drug benefit; Rebates for Medicare Part D; S. 2041, The Promoting Life - Saving New Therapies for Neonates Act of 2015; the Independent Payment Advisory Board (IPAB).
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHANE DOUCET New | Legislative Assistant for Rep Chris John |
| SUSAN HIRSCHMANN | — |
| CHERYL LYNN JAEGER | — |
| KARINA LYNCH | — |
| MELINDA M MAXFIELD New | — |
| ERIN BOOK MULLEN | — |
| GEORGE OLSEN | — |
| DAVID A STARR New | — |
Health Issues HCR
21st Century Cures Initiative (House Energy and Commerce Committee) and Innovation for Healthier Americans (Senate HELP Committee); Possible pharmaceutical provisions in the Continuing Resolution and the Consolidated Appropriations Act, 2016; Drug safety and drug counterfeiting; Drug importation; Authorized generics; Drug company patent settlements; Prescription drug advertising; Federal preemption for prescription drugs; Implementation of Precision Medicine Initiative.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHANE DOUCET | Legislative Assistant for Rep Chris John |
| JACK STEVEN HART | — |
| SUSAN HIRSCHMANN | — |
| MATTHEW B HOEKSTRA | — |
| CHERYL LYNN JAEGER | — |
| KARINA LYNCH | — |
| MELINDA M MAXFIELD | — |
| ERIN BOOK MULLEN | — |
| GEORGE OLSEN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.